SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-009567
Filing Date
2019-10-31
Accepted
2019-10-31 16:07:15
Documents
117
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q irwd-20190930x10q47905d.htm   iXBRL 10-Q 3082950
2 EX-31.1 ex-31d1.htm EX-31.1 18530
3 EX-31.2 ex-31d2.htm EX-31.2 18499
4 EX-32.1 ex-32d1.htm EX-32.1 8465
5 EX-32.2 ex-32d2.htm EX-32.2 8607
  Complete submission text file 0001558370-19-009567.txt   13107151

Data Files

Seq Description Document Type Size
6 EX-101.SCH irwd-20190930.xsd EX-101.SCH 100367
7 EX-101.CAL irwd-20190930_cal.xml EX-101.CAL 113329
8 EX-101.DEF irwd-20190930_def.xml EX-101.DEF 487646
9 EX-101.LAB irwd-20190930_lab.xml EX-101.LAB 796918
10 EX-101.PRE irwd-20190930_pre.xml EX-101.PRE 800583
22 EXTRACTED XBRL INSTANCE DOCUMENT irwd-20190930x10q47905d_htm.xml XML 2311456
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34620 | Film No.: 191183711
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences